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Human growth is influenced not only by environmental and internal factors but also by a large number of different
genes. One of these genes, SHOX, is believed to play a major role in growth, since defects in this homeobox-
containing gene on the sex chromosomes lead to syndromal short stature (Le´ri-Weill dyschondrosteosis, Langer
mesomelic dysplasia, and Turner syndrome) as well as to idiopathic short stature. We have analyzed 118 unrelated
patients with Le´ri-Weill dyschondrosteosis and 11,500 patients with idiopathic short stature for deletions encom-
passing SHOX. Deletions were detected in 34% of the patients with Le´ri-Weill dyschondrosteosis and in 2% of
the patients with idiopathic short stature. For 27 patients with Le´ri-Weill dyschondrosteosis and for 6 with idiopathic
short stature, detailed deletion mapping was performed. Analysis was performed by polymerase chain reaction with
the use of pseudoautosomal polymorphic markers and by fluorescence in situ hybridization with the use of cosmid
clones. Here, we show that, although the identified deletions vary in size, the vast majority (73%) of patients tested
share a distinct proximal deletion breakpoint. We propose that the sequence present within this proximal deletion
breakpoint “hotspot” region predisposes to recurrent breaks.
Introduction
Short stature has been defined as height 12 SD below
the mean for age and sex. This corresponds to the short-
est 2.3% of children. Although it is clear that multiple
factors contribute to final height, genetic factors play a
crucial role. Deletions within the distal short arm of the
human X chromosome, for example, lead to multiple
phenotypes, including short stature, chondrodysplasia
punctata, mental retardation, steroid sulfatase defi-
ciency, and Kallmann syndrome, and have been found
as isolated entities and as part of a contiguous gene
syndrome (Ballabio et al. 1989). Deletions that are nor-
mally restricted to the pseudoautosomal region (PAR1)
encompassing the short-stature homeobox gene (SHOX
[MIM 312865]) have been found in patients with Le´ri-
Weill dyschondrosteosis (LWD [MIM 127300]) and in
those with idiopathic short stature (ISS [MIM 604271])
(Ellison et al. 1997; Rao et al. 1997b; Belin et al. 1998;
Shears et al. 1998; Cormier-Daire et al. 1999, 2001;
Spranger et al. 1999; Blaschke and Rappold 2000; Gri-
gelioniene et al. 2000; Rappold et al. 2002; Binder et
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al. 2003; Morizio et al. 2003). LWD is a mesomelic
short-stature syndrome characterized by a skeletal fore-
arm abnormality termed “Madelung deformity.” Ap-
proximately 50%–100% of cases of LWD are due to
complete deletions or intragenic mutations of the SHOX
gene (Grigelioniene et al. 2000; Schiller et al. 2000; Cor-
mier-Daire et al. 2001; Ross et al. 2001). Evidence sug-
gests that roughly two-thirds of SHOX-deficient patients
with LWD have deletions, whereas one-third of SHOX-
deficient patients with LWD have point mutations (Cor-
mier-Daire et al. 2001; Falcinelli et al. 2001; Grigelion-
iene et al. 2001; Huber et al. 2001; Ross et al. 2001;
Flanagan et al. 2002). In the cohort of patients with ISS,
SHOX mutations were found in 2.4% of the patients,
of which 80% (2.0% of the cohort) have been identified
as carrying complete gene deletions (Rappold et al.
2002). Binder et al. (2003) confirmed these findings in
a screen of individuals with ISS that revealed complete
SHOX gene deletions in 12% of the affected individuals.
On the basis of this prevalence of SHOX deletions in
patients with ISS and under the assumption that the
disorder found in most people with short stature is id-
iopathic, SHOX deletions are estimated to occur in ∼1
in 2,000 individuals in the total population (Rappold et
al. 2002; Binder et al. 2003). Moreover, others have
found SHOX deletions in up to 7.1% of patients with
short stature of unknown cause (Morizio et al. 2003).
Although large deletions rarely account for the ma-
jority of mutations at a given locus (Cooper et al. 1998;
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Antonarakis et al. 2000), a high frequency of deletions
has been found in several inherited disorders. For in-
stance, large gene deletions occur in Duchenne muscular
dystrophy (DMD), in which two-thirds of all affected
individuals display a deletion of one or more exons of
the dystrophin gene (DMD) (Muntoni et al. 2003), and
in X-linked ichthyosis, in which the majority of the
patients carry a 1.9-Mb deletion encompassing the STS
locus (Hernandez-Martin et al. 1999).
To gain a better understanding of the mechanism un-
derlying SHOX deletions, we analyzed deletion break-
points in 27 patients with LWD and in 6 patients with
ISS. We identified a high incidence of breakpoints (73%)
in a 5-kb region proximal to the SHOX gene, suggesting
that this breakpoint may represent a hotspot for dele-
tions leading to short stature.
Material and Methods
Subjects
Peripheral blood samples were taken from 118 indi-
viduals with LWD and from 11,500 individuals with ISS
after informed consent was obtained. Thirty-three pa-
tients (27 patients with LWD and 6 patients with ISS)
were studied in detail for deletion sizes. Six patients with
ISS and SHOX deletions were from a previous screen
(Rappold et al. 2002 and authors’ unpublished data).
The patients were of both sexes (22 females and 11
males) and were of European origin (17 from Germany,
5 from the Netherlands, 5 from France, 3 from Spain,
1 from the Czech Republic, 1 from Croatia, and 1 from
Poland). All individuals were unrelated and had been
examined by endocrinologists. Short stature was diag-
nosed when height, adjusted for sex and chronological
age, was below the 3rd percentile or !2 SDs of national
height standards. Exclusion criteria for this study were
growth hormone deficiency, growth hormone receptor
defect, malignant neoplastic disease, chronic infectious
disease, active rheumatoid arthritis, diabetes mellitus,
renal insufficiency, hepatic disease, congestive heart fail-
ure, gonadal dysgenesis, or abnormal diet. LWD diag-
nosis was based on the presence of Madelung deformity,
bowing of the forearms, and mesomelic short stature.
For some of the patients, X-ray analysis of the forearm
was performed.
PCR-Based Microsatellite Analysis
Genomic DNA was extracted from blood samples and
was used for amplification with the primers DXYS201
(SHOX 5CA forward: CAT GTC ATA TAT ATA TGT
GAT CC; SHOX 5CA reverse: GAC ACA GAA ATC
CTT CAT AAA), DXYS233 (233 forward: TGG GAA
TTC GAG GCT G; 233 reverse: TGA TTT CCA TCC
TGG GGT), and CAII (CAII forward: ATA TCA GAA
AAG ACT GTG TTC TAC; reverse: TAG TAG GTT
GCA AAG GCA TCT G). Twenty picomoles of each
primer were used with 100 ng of DNA—together with
2 U of Goldstar DNA polymerase (Eurogentec), 10 pmol
dNTP (Fermentas), and 75 mmol MgCl2—in the buffer
provided with the enzyme. PCR was performed in a
Peltier Thermal Cycler (PTC-200), starting with dena-
turation (95C for 5 min), followed by 35 cycles of am-
plification (95C for 30 s, 55C for 30 s, and 72C for
45 s) and a final elongation step (72C for 5 min). The
PCR products were loaded on a polyacrylamide gel
(10%) and were stained with AgNO3 solution.
FISH Analysis
Biotinylated cosmid DNA was hybridized to inter-
phase and metaphase chromosomes of lymphocytes of
patients, as described elsewhere (Lichter and Cremer
1992). FISH was performed using cosmids 11D2
(LLN0YCO3′M′11D2), 56G10 (LLN0YCO3′M′56G10),
HO32 (LLNLc110HO32), 25D5 (LLN0YCO3′M′25D5),
110A7 (LLN0YCO3′M′110A7), 110E3 (LLN0YCO3′-
M′110E3), 43C11 (LLN0YCO3′M′43C11), 15D10
(LLN0YCO3′M′15D10), 34F5 (LLN0YCO3′M′34F5),
G0411 (ICRFc104G0411), 9E3 (LLN0YCO3′M′9E3),
29B11 (LLN0YCO3′M′29B11), P0117 (ICRFc104P0117),
ANT3 (ICRFc104D0137), and 12E11 (LLN0YCO3′-
M′12E11). Hybridization signals were detected via avidin-
conjugated fluorescein isothiocyanate (FITC). Chromo-
somes were counterstained with 4′,6-diamidino-2-phen-
ylindole (DAPI). Images of FITC- and DAPI-stained
chromosomes were taken separately, using a cooled
charge-coupled–device camera system (Photometrics).
SNP Analysis
SNPs that mapped to the critical breakpoint region in
PAR1 were identified by searching dbSNP. Additional
SNPs in this area were identified during the sequencing
process and were further used for confirming hetero-
zygosity. SNPs within the markers DXYS86, DXYS59
(dbSNP accession number rs6644571), C7/SNPs (dbSNP
accession numbers rs1016964 and rs3995647), C8/
SNPs (dbSNP accession numbers rs2399945 and
rs2399946), C9/SNPs, and C10/SNPs in the respective
patients and their families were analyzed for heterozy-
gosity by sequence analysis with the use of the following
primers: P131 (forward: TCT GCC ATC CTA ATG ATG
GT; reverse: AGA AGT TTC TTC TCC ACC TG),
DXYS59 (forward: CAT TAA GCT GAT TAG CC AAT;
reverse: AGA GCT CCA ATA TAT GCC AT), C7SNPs
(forward: TAC GTG GTA GGG AGG AAG ATT GGA;
reverse: ATC CAA GCA ATT GTC AGG GAT GGC),
C8SNPs (forward: TCC TCC CAG TTG TCC CAG
TTG TAT; reverse: GCT GCC CAT GAC AGG GGA
CTA ACG), C9SNPs (forward: GCT GCT ACT AAG
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TTA ACT GG; reverse: CAG ATA GAC AAT ATT TTC
AG), and C10SNPs (forward: CGT CTC TTC CTT ATC
ACT TG; reverse: TAA CCG CAG TGA AAC GTC CC).
Sequencing was performed on a MegaBACE sequencer
(Amersham Bioscience) by use of the DYEnamic ET Ter-
minator Cycle Sequencing kit, in accordance with the
manufacturer’s instructions.
Secondary-Structure Prediction of the Hotspot Region
by Computational Analysis
For secondary-structure prediction, a 6-kb sequence
encompassing the hotspot region as well as 6-kb se-
quences of the direct proximal and distal adjacent
regions were submitted to the Mfold server (Zuker
2003). Structures with the lowest free-energy values were
selected for analysis.
Results
Deletion analysis was performed for 118 unrelated pa-
tients with LWD, by use of three polymorphic markers—
CAII, DXYS201 (CA repeat), and DXYS233—that re-
side between 520 kb and 870 kb from the telomere in
PAR1 (see fig. 1). In cases of homozygosity of at least
two of the three markers, deletion mapping was per-
formed by FISH with the use of cosmids from a cosmid
contig that was previously established by our group (Rao
et al. 1997a).
In total, we found deletions encompassing SHOX in
40 individuals (34% of the 118 patients with LWD).
For 27 patients with LWD, we were able to perform a
detailed deletion mapping with the use of 15 PAR1 cos-
mids in total (fig. 1). The deletion sizes vary extensively,
with the smallest comprising ∼90 kb (patient LWD21)
and the largest comprising 12.5 Mb (patients LWD25–
LWD27) (table 1). However, most interestingly, 20
(74%) of 27 patients share a distinct breakpoint that is
defined by the presence of a hybridization signal of cos-
mid P0117 and the absence of a signal of cosmid 29B11,
which maps the breakpoint within the genomic se-
quence represented within cosmid P0117 (fig. 2).
This high incidence prompted us to investigate
whether patients with ISS present similar deletion break-
points, since 2%–3% of cases of ISS result from SHOX
mutations (Rappold et al. 2002; Binder et al. 2003). We
determined that the proximal deletion breakpoint sim-
ilarly localizes within cosmid P0117 in four (67%) of
the six patients with SHOX deletions, which indicates
the clustering of the deletion breakpoint within a rel-
atively small interval. Cosmid 29B11 harbors the probe
AK1 (DXYS163), which detects a variable number of
tandem repeats (VNTR) locus ∼65 kb proximal to the
SHOX gene (Klink et al. 1993). We used AK1 for
Southern hybridization on TaqI-digested genomic
DNAs and found that AK1 is absent in all patients
carrying the deletion (data not shown). Cosmid P0117,
however, was found by FISH analysis to be present
in all the patients with deletions, on both alleles of
the sex chromosomes.
On the basis of these findings, further mapping of the
breakpoint region was achieved for seven patients
(LWD1, LWD6, LWD7, LWD10, LWD15, LWD16, and
ISS30) by use of SNP analysis. Cosmid P0117 contains
the microsatellite marker P117 (DXYS417) (Wapenaar
et al. 1992), and further SNP markers were selected in
the vicinity of P117 (three distal and three proximal
markers [see fig. 3]). SNP analysis mapped the break-
points to an interval of 5 kb that is directly distal to
P117 in all affected individuals. Sequence analysis of
this critical region by use of the Tandem Repeat Finder
of the University of California–Santa Cruz (UCSC) Ge-
nome Browser revealed a high occurrence of STRs
(∼85%) within the hotspot region.
Since tandem repeats can form unusual secondary
structures, secondary-structure–prediction analysis was
performed using the Mfold web server. Unlike the neigh-
boring regions, the hotspot region showed (in Mfold
analysis) an extensive secondary structure that is char-
acterized by strong DNA bending and a free energy of
617.9 kcal/mol, together with hairpins and loops (fig.
4). Sequence and structure analysis of the tandem re-
peats revealed that they can vary in length but that they
consist mostly of homologous units of 27 bp in a head-
to-tail arrangement. In conclusion, the high incidence
of breakpoints on cosmid P0117 is very likely due to
the accumulation of STR sequences that may cause ge-
nomic instability by abnormal secondary-structure for-
mation, including DNA bending, which, in turn, might
explain the hotspot of deletions observed in the ana-
lyzed patients with short stature.
Discussion
The distal short arm of the human X chromosome is
frequently subjected to deletion events that lead to ge-
netic disorders such as short stature, chondrodysplasia
punctata, mental retardation, ichthyosis, and Kallmann
syndrome (Ballabio et al. 1989). We were interested in
defining the deletion breakpoints in the vicinity of the
SHOX gene, and we found that 24 (73%) of the 33
analyzed individuals share a common deletion break-
point within a 5-kb interval. SHOX deletions account
for 2.0%–7.1% of short stature of unknown cause (Rap-
pold et al. 2002; Binder et al. 2003; Morizio et al. 2003),
indicating that the major breakpoint that we identified
contributed to the deletions in possibly 11% of patients
with idiopathic short stature. Of all the tested patients
with LWD and Xp deletions, the majority (73%) har-
bor this breakpoint on cosmid P0117. This leaves the
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Figure 1 Deletion mapping of 27 patients with LWD (patients LWD1–LWD27) and 6 patients with ISS (patients ISS28–ISS33). Patients
LWD2, LWD3, LWD4, LWD5, LWD8, LWD9, LWD19, LWD20, LWD22, and LWD28 have been described elsewhere as presenting a SHOX
deletion (Schiller et al. 2000); however, the exact extent of the deletion sizes as well as the breakpoints were not defined. Blackened areas
indicate the presence of the respective cosmid clone on both of the patient’s sex chromosomes; unblackened areas indicate the absence of a
cosmid clone on one sex chromosome; shaded areas indicate the breakpoint region. The map positions of the cosmid clones are indicated by
horizontal lines and the clone abbreviation (see the “Material and Methods” section). The approximate distance from the telomere is given in
kb. Microsatellite markers are indicated with vertical lines at their respective map position. The genomic locus of the SHOX gene is indicated
in gray and resides ∼555.1–582.3 kb from the telomere. The deletion hotspot is defined by the presence of cosmid P0117 and the absence of
cosmid 29B11.
DXYS233 locus intact (fig. 1), which, in some screens,
was used as an indicator of a SHOX deletion (e.g.,
Binder et al. 2003), suggesting that the true incidence of
SHOX deletions in those studies may be considerably
higher than previously estimated. A diagnostic test for
SHOX deletions should therefore encompass markers
next to the gene (e.g., CA markers CAII or DXYS201)
and should not consider DXYS233.
The DNA instability that we observed in the overlap
of cosmid clones P0117 and 29B11 is most likely due
to the abundance of STRs that cause an extensive sec-
ondary-structure formation, as shown by the Mfold
analysis (fig. 4). In contrast to the frequent proximal
deletion breakpoint, the distal breakpoints vary consid-
erably, with at least seven different breakpoints, as de-
fined by FISH analysis. This variation might be due to
weaker genomic instabilities at the respective positions
in PAR1. PAR1 itself is a region that is highly active in
recombination (Rappold et al. 1994). Crossovers are
not distributed randomly but cluster in specific recom-
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Figure 2 FISH of cosmids 29B11 and P0117 to metaphase (A)
and interphase chromosomes (B) of patient LWD10. The absence of
the signal of cosmid 29B11 and the presence of the signal of cosmid
P0117 locates the breakpoint on cosmid P0117.
Figure 3 Results of SNP analysis of the critical breakpoint region
of the overlap of cosmid clones P0117 and 29B11. This region—at
∼655–678 kb from the telomere on the X chromosome and at 57–80
kb on the BAC clone RP13-76L22 (GenBank accession number
AL683871.15) (on the basis of the UCSC Genome Browser human
May 2004 assembly and NCBI build 35)—harbors the VNTR AK1
(655,357–656,210 bp), as well as the microsatellite marker P117
(672,153–675,202 bp). SNPs within AK1, DXYS86 (P131), DXYS59
(dbSNP accession number rs6644571 at 666,749 bp), C7/SNP (dbSNP
accession numbers rs1016964 at 671,526 bp and rs3995647 at
671,472 bp), and C8/SNP (dbSNP accession numbers rs2399945 at
676,936 bp and rs2399946 at 676,787 bp), as well as the few as-yet-
unpublished SNPs within C9/SNP and C10/SNP, were checked for
heterozygosity in seven families (patients LWD1, LWD6, LWD7,
LWD10, LWD15, LWD16, and ISS30). The breakpoint of ∼5 kb (in-
dicated in gray) could be defined by the heterozygosity of the SNPs
within C7/SNP and the absence of heterozygosity of SNPs within
DXYS59. SHOX maps to 555,079–582,318 bp, AK1 to 655,357–
656,210 bp, DXYS86 to 665,323–665,477 bp, DXYS59 to 666,696–
666,875 bp, C7/SNP to 671,103–671,885 bp, P117 to 672,153–
675,202 bp, C8/SNP to 676,618–676,192 bp, C9/SNP to 679,663–
681,329 bp, and C10/SNP to 683,363–684,552 bp (from the
telomere).
bination hotspots (May et al. 2002). Sequence com-
parisons of the breakpoint regions did not reveal se-
quence compositions that were similar to that the
P0117 cosmid, suggesting that homologous recombi-
nation may not be the underlying mechanism for the
deletions observed. Rather, we speculate that the un-
usual secondary structure of the proximal region, to-
gether, perhaps, with double-strand DNA breaks, may
lead to recombination in this genomic region (Klein et
al. 1996). The published sequence of the human X chro-
mosome is 99.3% complete, and intrachromosomal du-
plications account for 2.6% of the X chromosome (Ross
et al. 2005). Consistently, our sequence analysis and the
data reported by Ross et al. (2005) exclude an intrach-
romosomal segmental duplication within the region of
interest.
Other mechanisms underlying deletions, such as un-
equal crossover, have been previously described in the
Xp22 region and lead to a high deletion frequency in
X-linked ichthyosis (Shapiro et al. 1989; Yen et al.
1990). Interestingly, with a prevalence of 1 in 6,000
males, X-linked ichthyosis shows one of the highest in-
cidences of deletions observed so far. Ninety percent of
all patients exhibit deletion of the steroid sulfatase gene
that results from homologous recombination between
repetitive S232-like VNTR sequences that reside in the
gene’s flanking region (Yen et al. 1990; Li et al. 1992).
Furthermore, approximately two-thirds of the patients
suffering from DMD or Becker muscular dystrophy dis-
play deletions of one or many exons in the 2.5-Mb
region encompassing the DMD gene (Blonden et al.
1989; Muntoni et al. 2003). Two deletion hotspots were
found, one residing in the central part of the DMD gene
and the other in the 5′ end of the gene, and screening
of these two regions identified ∼98% of all deletions.
A detailed analysis of the more distal clustering of
breakpoints in intron 44, however, has shown that the
breakpoints are actually spread over a large intron of
240 kb (see the Leiden Muscular Dystrophy Pages). A
real clustering at the sequence level, therefore, does not
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Figure 4 Secondary-structure prediction, made by use of Mfold analysis, of the sequence harboring the hotspot region (B) and the 6-kb
sequences distal (A) and proximal (C) to it. The free-energy values for each secondary-structure prediction are 902 kcal/mol (A), 617.9
kcal/mol (B), and 677.8 kcal/mol (C). High DNA bending and an extensive secondary-structure formation are observed only in the hotspot
region (B).
exist. With a prevalence of 1 in 3,500 males (i.e., 1 in
7,000 in the total population), the two deletion hotspots
reach a frequency of ∼1 in 11,000 individuals in the
population (Bogdanovich et al. 2003).
The presence of a deletion hotspot in 73% (95% CI
56%–85%) of patients with short stature and with a
SHOX deletion suggests a prevalence of this breakpoint
of ∼1:2,000 in the total population (95% CI 1:2,350–
1:3,570), which is based on the assumption that the
disorder found in most people with short stature is id-
iopathic. This implies that the recurrent deletion break-
point identified in this study is rather frequent in the
heterogeneous group of patients with short stature and,
furthermore, may represent the most frequent known
deletion breakpoint leading to disease.
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